查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571923

全球动脉支架市场

Arterial Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球动脉支架市场将达252亿美元

2023年全球动脉支架市场预计为145亿美元，预计到2030年将达到252亿美元，2023-2030年分析期间复合年增长率为8.2%。冠状动脉支架是本报告分析的细分市场之一，复合年增长率为8.1%，预计到分析期结束时将达到128亿美元。在分析期间，外周支架细分市场的复合年增长率预计为 8.4%。

美国市场预计38亿美元，中国预计复合年增长率12.0%

预计2023年美国动脉支架市场规模将达38亿美元。中国作为世界第二大经济体，预计2030年市场规模将达63亿美元，2023-2030年分析期间复合年增长率为12.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.2% 和 7.4%。在欧洲，德国预计复合年增长率为 5.0%。

全球动脉支架市场－主要趋势与驱动因素总结

为什么动脉支架对于心血管疾病的治疗至关重要？

动脉支架已成为治疗心血管疾病，特别是冠状动脉疾病（CAD）和周边动脉疾病（PAD）患者的重要医疗设备。这些小管状装置用于打开阻塞或狭窄的动脉，以确保血液适当地流向心臟和其他重要器官。心血管疾病仍然是全世界死亡的主要原因，动脉支架在减少心臟病、中风和肢体缺血等併发症发挥重要作用。肥胖、糖尿病和高血压等与生活方式相关的健康状况的增加进一步增加了对动脉支架的需求，使其成为现代心血管治疗的重要组成部分。

科技进步如何彻底改变动脉支架设计？

药物释放型支架（DES）和生物可吸收支架的开拓是动脉支架市场的重要技术进步。药物释放型支架随着时间的推移释放药物以防止动脉血管再阻塞。生物可吸收支架一旦达到其目的就会逐渐溶解，是减少与传统金属支架相关的长期併发症的有前途的解决方案。此外，光同调断层扫瞄（OCT）和血管内超音波（IVUS）等影像技术的进步提高了支架置入的精确度，提高了支架置入术的成功率。这些创新为管理复杂的心血管疾病提供更安全、更有效的解决方案，正在改变支架市场。

哪些监管标准正在塑造动脉支架市场？

监管标准在动脉支架市场中发挥重要作用。这是因为这些医疗设备的安全性和有效性在用于患者之前必须经过仔细评估。 FDA 和欧洲药品管理局 (EMA) 等机构要求支架经过严格的临床测试，以确保它们符合严格的品质和安全标准。这包括证明支架保持动脉通畅性的能力，而不会产生凝血或发炎等副作用。上市后监测也至关重要，使监管机构能够监测患者的长期结果并识别与新支架技术相关的新风险。遵守这些标准对于製造商获得医疗保健提供者和患者的核准并建立信任至关重要。

推动动脉支架市场成长的因素有哪些？

动脉支架市场的成长受到多种因素的推动，例如心血管疾病盛行率的上升、支架设计的技术进步以及对微创手术的需求不断增加。全球心臟病和中风的负担正在推动对基于支架的干预措施的需求不断增长，特别是当医疗保健系统转向预防性护理和早期诊断时。药物释放型和生物可吸收支架等创新正在改善患者的治疗效果，并在已开发市场和新兴市场越来越多地采用。人们越来越偏好恢復更快、併发症更少的微创手术，这进一步推动了动脉支架的使用。此外，新兴国家不断扩大的医疗基础设施正在增加先进心血管治疗的机会，为市场成长创造了新的机会。

受访企业范例（共46家）

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Stentys SA
  • Terumo Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP16154

Global Arterial Stents Market to Reach US$25.2 Billion by 2030

The global market for Arterial Stents estimated at US$14.5 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Peripheral Stents segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 12.0% CAGR

The Arterial Stents market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Arterial Stents Market - Key Trends & Drivers Summarized

Why Are Arterial Stents Crucial for Managing Cardiovascular Diseases?

Arterial stents have become an essential medical device in the treatment of cardiovascular diseases, particularly in patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). These small, tube-like devices are used to open up blocked or narrowed arteries, ensuring proper blood flow to the heart and other critical organs. With cardiovascular diseases remaining the leading cause of death worldwide, arterial stents play a vital role in reducing complications such as heart attacks, strokes, and limb ischemia. The growing incidence of lifestyle-related health conditions, including obesity, diabetes, and hypertension, has further driven the demand for arterial stents, making them a key component of modern cardiovascular care.

How Are Technological Advances Revolutionizing Arterial Stent Design?

The development of drug-eluting stents (DES) and bioresorbable stents represents a significant technological advancement in the arterial stent market. Drug-eluting stents release medications over time to prevent restenosis, the re-narrowing of the artery, which has improved patient outcomes by reducing the need for repeat interventions. Bioresorbable stents, which gradually dissolve after fulfilling their purpose, offer a promising solution for reducing long-term complications associated with traditional metal stents. Furthermore, advances in imaging technology, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), have improved the precision with which stents are deployed, enhancing the success of stenting procedures. These innovations are transforming the stent market by offering safer, more effective solutions for managing complex cardiovascular conditions.

What Regulatory Standards Are Shaping the Arterial Stents Market?

Regulatory standards play a crucial role in the arterial stents market, as the safety and efficacy of these medical devices must be carefully evaluated before they can be used in patients. Agencies such as the FDA and European Medicines Agency (EMA) require that stents undergo rigorous clinical testing to ensure they meet stringent quality and safety standards. This includes demonstrating the stent's ability to maintain arterial patency without causing adverse effects such as blood clotting or inflammation. Post-market surveillance is also essential, as it allows regulatory bodies to monitor long-term patient outcomes and identify any emerging risks associated with new stent technologies. Compliance with these standards is vital for manufacturers to gain approval and build trust with healthcare providers and patients.

What Factors Are Driving the Growth of the Arterial Stents Market?

The growth in the arterial stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and the increasing demand for minimally invasive procedures. The global burden of heart disease and stroke is prompting greater demand for stent-based interventions, particularly as healthcare systems shift toward preventive care and early diagnosis. Technological innovations such as drug-eluting and bioresorbable stents are improving patient outcomes, leading to increased adoption in both developed and emerging markets. The growing preference for minimally invasive procedures, which offer quicker recovery times and reduced complications, is further boosting the use of arterial stents. Additionally, the expansion of healthcare infrastructure in developing countries is opening new opportunities for market growth as access to advanced cardiovascular care increases.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Group, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Stentys SA
  • Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Arterial Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Driving Demand for Arterial Stents
    • Technological Advancements in Stent Design Enhancing Market Growth
    • Rising Adoption of Minimally Invasive Procedures Boosting Stent Utilization
    • Expansion of Aging Population Contributing to Growth in Arterial Stent Market
    • Development of Biodegradable Stents Creating New Opportunities for Market Expansion
    • Growing Use of Drug-Eluting Stents for Long-Term Efficacy Driving Demand
    • Increased Healthcare Spending in Emerging Economies Fuelling Market Growth
    • Rising Focus on Early Detection and Treatment of Arterial Blockages Boosting Adoption
    • Expansion in Clinical Trials and R&D Activities Supporting Technological Innovation
    • Government Initiatives Aimed at Improving Cardiovascular Care Increasing Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Arterial Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Arterial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Coronary Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Coronary Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Coronary Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Carotid Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Carotid Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Iliac Artery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Iliac Artery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arterial Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arterial Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arterial Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arterial Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Arterial Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Arterial Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arterial Stents by Product - Coronary Stents and Peripheral Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arterial Stents by Product - Coronary Stents and Peripheral Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Arterial Stents by Product - Percentage Breakdown of Value Sales for Coronary Stents and Peripheral Stents for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arterial Stents by Application - Coronary Artery, Carotid Artery, Iliac Artery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Arterial Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery, Carotid Artery, Iliac Artery and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION